Mishcon de Reya page structure
Site header
Menu
Main content section
Peter Crane

The Mishcon Innovations Series: Peter Crane

Posted on 2 September 2025

Peter Crane is the co-founder and CEO of Entelo Bio, a gene sequencing company combining cutting edge chemistry with machine learning to unlock transformative therapies for patients with chronic diseases.

With a career spanning lab automation,  biomanufacturing and cancer proteomics (and as an investor in hard science Start-ups), it was his frustration with existing genomic methods that drove Peter and his 3 academic co-founders to spin Entelo Bio out of Oxford University in 2023.

Hungry to look at biology in a new way, their isoform sequencing platform aims to reduce the error rate and cost of long read single cell sequencing.

Listen here

How can we help you?
Help

How can we help you?

Subscribe: I'd like to keep in touch

If your enquiry is urgent please call +44 20 3321 7000

Crisis Hotline

I'm a client

I'm looking for advice

Something else